Medicare Enrolled

Dr. Alexander Shraga, MD, MPH

Dermatology · Spotswood, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
296 SUMMERHILL RD STE 100, Spotswood, NJ 08884
7323901883
Registered in NPPES since 2006
NPI: 1265460604 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Shraga from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shraga? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Shraga

Dr. Alexander Shraga is a dermatology specialist in Spotswood, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Shraga performed 648 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Shraga received a total of $6,089 from 48 pharmaceutical and/or device companies across 419 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Shraga is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ 648 Medicare services $6,089 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
648
Medicare services
Bottom 13% in NJ for dermatology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$55
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14
This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer.
204 $6 $30
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
148 $79 $147
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
79 $49 $159
Skin biopsy, tangential
A procedure to remove a sample of the first identified skin growth for laboratory examination.
45 $84 $242
Destruction of skin growths (warts/lesions), 1-14
This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface.
42 $101 $242
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
41 $97 $234
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
31 $50 $120
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
27 $109 $195
Additional skin growth biopsy
Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session.
20 $44 $120
Destruction of 15 or more precancerous skin growths
This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer.
11 $154 $444
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,089
Total received (2018-2024)
Avg $870/year across 7 years
Top 27% in NJ for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
419
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$274
2023
$62
2022
$872
2021
$765
2020
$824
2019
$1,740
2018
$1,551

Payments by company (2024)

Dermavant Sciences, Inc.
$45
Janssen Biotech, Inc.
$33
ABBVIE INC.
$32
SUN PHARMACEUTICAL INDUSTRIES INC.
$32
STRATA Skin Sciences, Inc.
$29
E.R. Squibb & Sons, L.L.C.
$27
Boehringer Ingelheim Pharmaceuticals, Inc.
$21
UCB, Inc.
$19
Galderma Laboratories, L.P.
$19
Lilly USA, LLC
$16
Top 3 companies account for 40.5% of 2024 payments
All-time payments by company (2018-2024) ›
Ortho Dermatologics, a division of Bausch Health US, LLC
$613
Galderma Laboratories, L.P.
$443
Janssen Biotech, Inc.
$384
Novartis Pharmaceuticals Corporation
$341
LEO Pharma Inc.
$340
Almirall LLC
$328
Mayne Pharma Inc.
$301
Sun Pharmaceutical Industries Inc.
$276
Lilly USA, LLC
$230
EPI Health, LLC
$224
Amgen Inc.
$205
PFIZER INC.
$173
ABBVIE INC.
$164
Incyte Corporation
$161
Celgene Corporation
$153
UCB, Inc.
$143
AbbVie Inc.
$136
Biofrontera Inc.
$113
Promius Pharma LLC
$101
DERMIRA, INC.
$99
AbbVie, Inc.
$99
Sebela Pharmaceuticals Inc.
$96
SUN PHARMACEUTICAL INDUSTRIES INC.
$74
GENZYME CORPORATION
$73
Encore Dermatology Inc.
$70
VYNE Pharmaceuticals Inc.
$68
Taro Pharmaceuticals USA, Inc.
$67
MAYNE PHARMA INC.
$61
Exeltis, USA Inc.
$53
STRATA Skin Sciences, Inc.
$45
Dermavant Sciences, Inc.
$45
Journey Medical Corporation
$45
Merck Sharp & Dohme Corporation
$42
Mylan Pharmaceuticals Inc.
$41
Regeneron Healthcare Solutions, Inc.
$30
Paratek Pharmaceuticals, Inc.
$29
Nabriva Therapeutics, plc
$28
Sandoz Inc.
$28
E.R. Squibb & Sons, L.L.C.
$27
Boehringer Ingelheim Pharmaceuticals, Inc.
$21
Verrica Pharmaceuticals Inc.
$16
ORGANOGENESIS INC.
$15
TARO PHARMACEUTICALS USA, INC.
$15
PruGen, Inc. Pharmaceuticals
$15
Pierre Fabre Pharmaceuticals, Inc.
$15
Blueprint Medicines Corporation
$15
Mission Pharmacal Company
$14
Novum Pharma, LLC
$14
Top 3 companies account for 23.7% of all-time payments
Associated products mentioned in payments ›
0.25% · ABSORICA · ABSORICA (isotretinoin) · ABSORICA LD · ADBRY · AKLIEF · ALDARA · ALTRENO · AMELUZ · AMZEEQ · ARAZLO · Absorica LD · Aczone · Alcortin A · Ameluz · Avar · BF-RhodoLED · BRYHALI · Bensal HP · Bimzelx · CLODERM · COSENTYX · Ceracade · Cimzia · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dermatological Psoriasis and Vitiligo Treatment · ENSTILAR · EPIDUO FORTE · EUCRISA · Enbrel · Exelderm · FINACEA · HALOG · HALOG (Halcinonide Cream · HALOG OINTMENT (Halcinonide Ointment · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · Impoyz · JUBLIA · JUBLIA EFINACONAZOLE · KERYDIN · NAFTIN · NUZYRA · Neocera · ONEXTON · OPZELURA · ORACEA · Olux · Otezla · PICATO · Puraply · QBREXZA · REMICADE · RETIN-A MICRO · RETIN-A-MICRO · RINVOQ · Recedo · SILIQ · SIVEXTRO · SKYRIZI · SOOLANTRA · SPEVIGO · Sernivo · Sernivo Spray · Seysara · Sitavig · Sivextro · Skyrizi · Sotyktu · TALTZ · TETRIX · TOPICORT (desoximetasone) Topical Spray · TREMFYA · TRI-LUMA · TRILUMA · Tremfya · USP) 0.1% · VTAMA · Veltin · Verdeso · Winlevi · XELJANZ · XTRAC · YCANTH
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a dermatology specialist in Spotswood?
Compare dermatologists in the Spotswood area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists in nearby ZIP areas
158
County median income
$109,028
Nearest hospital to ZIP centroid (approximate)
ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL
6.7 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Shraga is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Shraga experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Shraga performed 204 destruction of precancerous skin growths, 2-14 services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Shraga receive payments from pharmaceutical companies?
Yes. Dr. Shraga received a total of $6,089 from 48 companies across 419 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shraga's costs compare to other dermatologists in Spotswood?
Dr. Shraga's average Medicare payment per service is $55. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shraga) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →